Found: 10
Select item for more details and to access through your institution.
Tryptophan-2,3-dioxygenase is regulated by prostaglandin E2 in malignant glioma via a positive signaling loop involving prostaglandin E receptor-4.
- Published in:
- Journal of Neurochemistry, 2016, v. 136, n. 6, p. 1142, doi. 10.1111/jnc.13503
- By:
- Publication type:
- Article
Surfactant protein D ( SP- D) deficiency is attenuated in humanised mice expressing the Met(11) Thr short nucleotide polymorphism of SP- D: implications for surfactant metabolism in the lung.
- Published in:
- Journal of Anatomy, 2013, v. 223, n. 6, p. 581, doi. 10.1111/joa.12120
- By:
- Publication type:
- Article
Microenvironmental Clues for Glioma Immunotherapy.
- Published in:
- Current Neurology & Neuroscience Reports, 2014, v. 14, n. 4, p. 1, doi. 10.1007/s11910-014-0440-1
- By:
- Publication type:
- Article
Correlated magnetic resonance imaging and ultramicroscopy (MR-UM) is a tool kit to assess the dynamics of glioma angiogenesis.
- Published in:
- eLife, 2016, p. 1, doi. 10.7554/eLife.11712
- By:
- Publication type:
- Article
Cancer immunotherapy by targeting IDO1/TDO and their downstream effectors.
- Published in:
- Frontiers in Immunology, 2015, v. 5, p. 1, doi. 10.3389/fimmu.2014.00673
- By:
- Publication type:
- Article
The Indoleamine-2,3-Dioxygenase (IDO) Inhibitor 1-Methyl-D-tryptophan Upregulates IDO1 in Human Cancer Cells.
- Published in:
- PLoS ONE, 2011, v. 6, n. 5, p. 1, doi. 10.1371/journal.pone.0019823
- By:
- Publication type:
- Article
Suppression of TDO-mediated tryptophan catabolism in glioblastoma cells by a steroid-responsive FKBP52-dependent pathway.
- Published in:
- Glia, 2015, v. 63, n. 1, p. 78, doi. 10.1002/glia.22734
- By:
- Publication type:
- Article
Chronic PPARγ Stimulation Shifts Amyloidosis to Higher Fibrillarity but Improves Cognition.
- Published in:
- Frontiers in Aging Neuroscience, 2022, v. 14, p. 1, doi. 10.3389/fnagi.2022.854031
- By:
- Publication type:
- Article
Pre-therapeutic microglia activation and sex determine therapy effects of chronic immunomodulation.
- Published in:
- Theranostics, 2021, v. 11, n. 18, p. 8964, doi. 10.7150/thno.64022
- By:
- Publication type:
- Article
Synergy of vaccination and agonist OX40 treatment--toward a mechanism-driven combination of glioma immunotherapy.
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 1, p. 4, doi. 10.1093/neuonc/nox169
- By:
- Publication type:
- Article